Article
Transvaginal mesh controversy: Careful patient selection is key
Howard Goldman, MD, discusses the possible effects of FDA reclassification of transvaginal mesh used for prolapse as well as the importance of adequate surgical training and patient selection.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Related Videos
Related Content
![Continuing an ARPI with [177Lu]Lu-PSMA-617 may not provide additional benefit in mCRPC](https://cdn.sanity.io/images/0vv8moc6/urologytimes/3f3104f5151a9c5bd47e129a09e8443bd772afdc-1200x905.jpg?fit=crop&auto=format)
